Geneos Wealth Management’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-106
| Closed | -$4K | – | 2620 |
|
|
2022
Q2 | $4K | Hold |
106
| – | – | ﹤0.01% | 2287 |
|
|
2022
Q1 | $4K | Hold |
106
| – | – | ﹤0.01% | 2435 |
|
|
2021
Q4 | $4K | Hold |
106
| – | – | ﹤0.01% | 2495 |
|
|
2021
Q3 | $5K | Sell |
106
-150
| -59% | -$7.08K | ﹤0.01% | 2479 |
|
|
2021
Q2 | $13K | Hold |
256
| – | – | ﹤0.01% | 2109 |
|
|
2021
Q1 | $12K | Hold |
256
| – | – | ﹤0.01% | 2313 |
|
|
2020
Q4 | $12K | Hold |
256
| – | – | ﹤0.01% | 2161 |
|
|
2020
Q3 | $10K | Hold |
256
| – | – | ﹤0.01% | 1958 |
|
|
2020
Q2 | $10K | Buy |
256
+150
| +142% | +$5.86K | ﹤0.01% | 1930 |
|
|
2020
Q1 | $3K | Hold |
106
| – | – | ﹤0.01% | 2217 |
|
|
2019
Q4 | $4K | Hold |
106
| – | – | ﹤0.01% | 2268 |
|
|
2019
Q3 | $3K | Hold |
106
| – | – | ﹤0.01% | 2262 |
|
|
2019
Q2 | $4K | Hold |
106
| – | – | ﹤0.01% | 2183 |
|
|
2019
Q1 | $4K | Hold |
106
| – | – | ﹤0.01% | 2117 |
|
|
2018
Q4 | $3K | Hold |
106
| – | – | ﹤0.01% | 2148 |
|
|
2018
Q3 | $5K | Hold |
106
| – | – | ﹤0.01% | 2076 |
|
|
2018
Q2 | $4K | Hold |
106
| – | – | ﹤0.01% | 2003 |
|
|
2018
Q1 | $4K | Hold |
106
| – | – | ﹤0.01% | 1920 |
|
|
2017
Q4 | $4K | Sell |
106
-63
| -37% | -$2.38K | ﹤0.01% | 1899 |
|
|
2017
Q3 | $7K | Buy |
169
+63
| +59% | +$2.61K | ﹤0.01% | 1697 |
|
|
2017
Q2 | $4K | Hold |
106
| – | – | ﹤0.01% | 1816 |
|
|
2017
Q1 | $4K | Sell |
106
-50
| -32% | -$1.89K | ﹤0.01% | 1764 |
|
|
2016
Q4 | $6K | Hold |
156
| – | – | ﹤0.01% | 1604 |
|
|
2016
Q3 | $6K | Hold |
156
| – | – | ﹤0.01% | 1535 |
|
|
2016
Q2 | $6K | Buy |
156
+50
| +47% | +$1.92K | ﹤0.01% | 1489 |
|
|
2016
Q1 | $4K | Buy |
+106
| New | +$4K | ﹤0.01% | 1572 |
|